XML 25 R8.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities      
Net income (loss) $ (262,746) $ (201,994) $ (189,070)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Loss (gain) on debt modification and extinguishment, net 40,087 20,762 2,702
Depreciation and amortization, net 370,302 367,511 350,408
Asset impairment 71,349 8,557 40,572
Equity in (earnings) loss of unconsolidated ventures 0 0 3,996
Distributions from unconsolidated ventures from cumulative share of net earnings 0 0 430
Amortization of entrance fees 0 0 (732)
Proceeds from deferred entrance fee revenue 0 0 477
Deferred income tax (benefit) provision (3,288) 3,617 7,590
Operating lease expense adjustment (14,349) (48,793) (45,739)
Change in fair value of derivatives 1,180 (434) (1,144)
Loss (gain) on sale of assets, net (2,368) (923) (37,737)
Loss (gain) on facility operating lease termination, net 4,139 0 0
Non-cash stock-based compensation expense 11,937 14,184 11,985
Property and casualty insurance income (3,875) (8,532) (18,920)
Other non-operating (income) loss 0 0 (2,542)
Changes in operating assets and liabilities:      
Accounts receivable, net (15,788) (3,498) 7,380
Prepaid expenses and other assets, net (15,481) (21,560) 21,629
Trade accounts payable and accrued expenses 4,464 15,697 2,448
Refundable fees and deferred revenue 5,280 5,221 (654)
Operating lease assets and liabilities for lessor capital expenditure reimbursements 32,187 16,362 9,844
Operating lease assets and liabilities for lease termination (5,000) 0 0
Net cash provided by operating activities 218,030 166,177 162,923
Cash Flows from Investing Activities      
Purchase of marketable securities 0 (49,054) (174,476)
Sale and maturities of marketable securities 20,000 60,000 197,100
Capital expenditures, net of related payables (201,525) (201,250) (233,205)
Acquisition of assets, net of cash acquired (311,028) (108,411) (574)
Investment in unconsolidated ventures 0 0 (7,589)
Proceeds from sale of assets, net 26,147 7,017 83,526
Property and casualty insurance proceeds 3,875 8,548 24,704
Change in lease acquisition deposits, net 5,000 (5,000) 0
Purchase of interest rate cap instruments (3,825) (10,149) (12,454)
Proceeds from interest rate cap instruments 5,627 20,563 9,890
Other (222) (330) (286)
Net cash provided by (used in) investing activities (455,951) (278,066) (113,364)
Cash Flows from Financing Activities      
Proceeds from debt 918,077 765,652 205,549
Repayment of debt and financing lease obligations (692,366) (594,997) (367,242)
Payment of financing costs, net of related payables (18,149) (25,157) (10,831)
Payments of employee taxes for withheld shares (6,473) (3,437) (1,915)
Net cash provided by (used in) financing activities 201,089 142,061 (174,439)
Net increase (decrease) in cash, cash equivalents, and restricted cash (36,832) 30,172 (124,880)
Cash, cash equivalents, and restricted cash at beginning of period 379,840 349,668 474,548
Cash, cash equivalents, and restricted cash at end of period $ 343,008 $ 379,840 $ 349,668